SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CORAL LABORATORIES

BSE: 524506 19 Aug 2025
Healthcare
₹ 479.95
Coral Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

CORAL LABORATORIES - Share Price & Details

Market Cap
₹172.0
High /Low
999.0 / 471.0
Stock P/E
9.36
Book Value
₹563.0
Dividend Yield
0.42
ROCE
17.4
ROE
₹13.1
Face Value
10.0
PEG Ratio
0.21
EVEBITDA
₹3.52
Debt
3.56
CMP / FCF
4,743
Debt to equity
₹0.02
NP Ann
24.2
High price all time
1,190
Piotroski score
₹7.0
Graham Number
797.0
No. Eq. Shares
0.36
Net CF
₹1.33
Net profit
17.9
Price to book value
0.85
Interest Coverage
₹195.0
Low price all time
23.3
Industry PE
33.8
Reserves
₹198
Free Cash Flow
₹-4.16

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
CORAL LABORATORIES LTD.306.1628.27281.357.91172.09.36
BDH INDUSTRIES LTD.183.9624.89178.224.3316717.5
BILCARE LTD.105.8033.6041.301.4316025.9

Peer Comparison Chart


About CORAL LABORATORIES

Coral Laboratories Ltd., with Security Code 524506, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Coral Laboratories Hits 52-Week Low Amidst Declining Sales and Profitability Challenges

(18 Aug 2025)
Coral Laboratories, a microcap in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low, reflecting a significant decline in performance...
Read more →

Coral Laboratories Reports Significant Financial Decline Amid Ongoing Challenges in June 2025 Results

(15 Aug 2025)
Coral Laboratories has reported its financial results for the quarter ending June 2025, showing a decline in net sales to Rs 18.82 crore and...
Read more →

Coral Laboratories Faces Continued Volatility Amid Declining Profitability Metrics

(14 Aug 2025)
Coral Laboratories has faced notable volatility, hitting a new 52-week low and declining for six consecutive days.
Read more →

Coral Laboratories standalone net profit declines 70.91% in the June 2025 quarter

(14 Aug 2025)
Net profit of Coral Laboratories declined 70.91% to Rs 2.56 crore in the quarter ended June 2025 as against Rs 8.80 crore during the previous quarter ended...
Read more →

Coral Laboratories Faces Significant Stock Volatility Amid Financial Challenges and Declining Sales

(14 Aug 2025)
Coral Laboratories has faced significant volatility, reaching a new 52-week low amid a notable decline in stock performance. The company has struggled over...
Read more →

Coral Laboratories Hits 52-Week Low Amidst Ongoing Financial Challenges and Market Underperformance

(13 Aug 2025)
Coral Laboratories has reached a new 52-week low, reflecting a year of underperformance compared to the market.
Read more →

Company Updates